| |
 |
|
Class Information
Number: 435/335
Name: Chemistry: molecular biology and microbiology > Animal cell, per se (e.g., cell lines, etc.); composition thereof; process of propagating, maintaining or preserving an animal cell or composition thereof; process of isolating or separating an animal cell or composition thereof; process of preparing a composition containing an animal cell; culture media therefore > Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof > Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) > Binds a lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)
Description: Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a lymphokine, cytokine, or any other secreted growth stimulatory factor, growth inhibitory factor, differentiation factor, or intercellular mediator that targets any type(s) of hematopoietic cell(s).
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7599066 |
Localized plasmon resonance sensor |
Oct. 6, 2009 |
| 7582292 |
Adipose tissue derived stromal cells for the treatment of neurological disorders |
Sep. 1, 2009 |
| 7575893 |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture |
Aug. 18, 2009 |
| 7541160 |
ELISA for VEGF |
Jun. 2, 2009 |
| 7541438 |
Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
Jun. 2, 2009 |
| 7537932 |
Antibodies that bind purified mammalian FLT3 ligands |
May. 26, 2009 |
| 7534870 |
Stable pharmaceutical composition comprising erythropoietin |
May. 19, 2009 |
| 7521206 |
Anti-TNF antibodies, compositions, methods and uses |
Apr. 21, 2009 |
| 7446174 |
Protein based TNF-.alpha. variants for the treatment of TNF-.alpha. related disorders |
Nov. 4, 2008 |
| 7438913 |
Substances and their uses |
Oct. 21, 2008 |
| 7425421 |
Method for the enumeration of micronucleated erythrocyte populations while distinguishing platelets and/or platelet-associated aggregates |
Sep. 16, 2008 |
| 7410781 |
IL-4/IL-13 specific polypeptides and therapeutic uses thereof |
Aug. 12, 2008 |
| 7411050 |
Monoclonal blocking antibody to human RANKL |
Aug. 12, 2008 |
| 7393684 |
Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies |
Jul. 1, 2008 |
| 7342110 |
Anti-CD33 antibodies and method for treatment of acute myeloid leukemia using the same |
Mar. 11, 2008 |
| 7341870 |
Dendritic cell line |
Mar. 11, 2008 |
| 7314722 |
Cytostatin II antibodies and methods |
Jan. 1, 2008 |
| 7309780 |
Antibodies to natural killer cell activating factor II |
Dec. 18, 2007 |
| 7294481 |
Method for producing recombinant proteins |
Nov. 13, 2007 |
| 7288250 |
Monoclonal antibodies against HMGB1 |
Oct. 30, 2007 |
| 7250493 |
FC fusion proteins of human erythropoietin with increased biological activities |
Jul. 31, 2007 |
| 7244823 |
TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
Jul. 17, 2007 |
| 7227003 |
Anti-TNF antibody fragments |
Jun. 5, 2007 |
| 7214658 |
Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection |
May. 8, 2007 |
| RE39548 |
Interleukin-5 specific recombinant antibodies |
Apr. 3, 2007 |
| 7183108 |
Selection and uses of lactic acid bacteria strains modulating non-specific immunity |
Feb. 27, 2007 |
| 7179893 |
Recombinant anti-TNF-.alpha. antibodies |
Feb. 20, 2007 |
| 7144987 |
Protein based tumor necrosis factor-receptor variants for the treatment of TNF related disorders |
Dec. 5, 2006 |
| 7138500 |
Antibodies to human 4-1BB |
Nov. 21, 2006 |
| 7122639 |
Chemokine alpha-2 antibodies |
Oct. 17, 2006 |
| 7101974 |
TNF-.alpha.variants |
Sep. 5, 2006 |
| 7087726 |
Anti-interferon-.alpha. antibodies |
Aug. 8, 2006 |
| 7060800 |
Antibodies binding the TNF related protein, TNF-X |
Jun. 13, 2006 |
| 7045301 |
Endothelial-monocyte activating polypeptide III antibodies |
May. 16, 2006 |
| 7030226 |
Fc fusion proteins of human erythropoietin with increased biological activities |
Apr. 18, 2006 |
| 7026132 |
Method of monitoring the effect of Cathepsin S inhibitors |
Apr. 11, 2006 |
| 7022521 |
Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
Apr. 4, 2006 |
| 6982082 |
Gene therapy by cell specific targeting |
Jan. 3, 2006 |
| 6979550 |
Method for diagnosis of, and determination of susceptibility to bovine mastitis |
Dec. 27, 2005 |
| 6960472 |
Monoclonal antibodies against N-Terminus proBNP |
Nov. 1, 2005 |
| 6955885 |
Human stanniocalcin-alpha |
Oct. 18, 2005 |
| 6921644 |
Follistatin-3 |
Jul. 26, 2005 |
| 6916628 |
Method for the measurement of soluble CD14 proteins separately |
Jul. 12, 2005 |
| 6900292 |
Fc fusion proteins of human erythropoietin with increased biological activities |
May. 31, 2005 |
| 6893813 |
Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy |
May. 17, 2005 |
| 6884594 |
Antibodies to growth factor HTTER36 |
Apr. 26, 2005 |
| 6855508 |
ELISA for VEGF |
Feb. 15, 2005 |
| 6803451 |
Cytokine receptor zalpha11 polypeptides |
Oct. 12, 2004 |
| 6756481 |
IL-23 receptor binding compositions |
Jun. 29, 2004 |
| 6740522 |
Antibodies against ligand for receptor activator of NF-kB |
May. 25, 2004 |
|
|
|
